Avexa Limited · Richmond, Victoria Australia(Australian: AVX)
Company Description
View Avexa Limited Locations On A US Map
This link will open in a new window
Avexa discovers drugs to treat vexing ailments. The pharmaceutical and research company works on the discovery and development of drugs for the treatment of infectious diseases, specifically HIV and antibiotic-resistant strains of bacteria. Avexa has worked on collaborative projects with Victorian College of Pharmacy, The Shanghai Institute of Organic Chemistry, North Carolina State University , and Georgetown University , among other institutions. The company was formed in 2004 when it was spun off from Australian drug discovery and biotechnology development company Amrad. Plans to merge with drugmaker Progen Pharmaceutical were canceled in 2009. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Avexa Limited Reports
Key Avexa Limited Financials
| Company Type | Public - Australian: AVX Headquarters |
| Fiscal Year-End | June |
| 2009 Employees | 27 |
Avexa Limited Executives
7 executives listed for Avexa Limited's Richmond, Victoria location.
| Title | Name & Bio | Contact |
| CEO and Director | Julian Chick | |
| CFO and Secretary | Stephen Kerr | |
| Chief Scientific Officer | Jonathan Coates |
Competition
Competitive Landscape for Avexa Limited
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top Avexa Limited Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
